Skip to main content
. 2021 Jan 12;10:e59755. doi: 10.7554/eLife.59755

Figure 6. Trends in estimated prevalence of O. viverrini infection in Southeast Asia.

Figure 6—source data 1. The results of the estimated prevalence of O. viverrini infection in Southeast Asia in different years.

Figure 6.

Figure 6—figure supplement 1. The population-adjusted estimated prevalence (median ± 95% BCI) in 2018 in four countries at administrative division of level 1.

Figure 6—figure supplement 1.

(A) Cambodia, (B) Laos, (C) Thailand, and (D) Vietnam.
Figure 6—figure supplement 1—source data 1. The results of the population-adjusted estimated prevalence in 2018 in four countries at administrative division of level 1.

Figure 6—figure supplement 2. The population-adjusted estimated prevalence (median ± 95% BCI) in 2013 in four countries at administrative division of level 1.

Figure 6—figure supplement 2.

(A) Cambodia, (B) Laos, (C) Thailand, and (D) Vietnam.
Figure 6—figure supplement 2—source data 1. The results of the population-adjusted estimated prevalence in 2013 in four countries at administrative division of level 1.

Figure 6—figure supplement 3. The population-adjusted estimated prevalence (median ± 95% BCI) in 2008 in four countries at administrative division of level 1.

Figure 6—figure supplement 3.

(A) Cambodia, (B) Laos, (C) Thailand, and (D) Vietnam.
Figure 6—figure supplement 3—source data 1. The results of the population-adjusted estimated prevalence in 2008 in four countries at administrative division of level 1.

Figure 6—figure supplement 4. The population-adjusted estimated prevalence (median ± 95% BCI) in 2003 in four countries at administrative division of level 1.

Figure 6—figure supplement 4.

(A) Cambodia, (B) Laos, (C) Thailand, and (D) Vietnam.
Figure 6—figure supplement 4—source data 1. The results of the population-adjusted estimated prevalence in 2003 in four countries at administrative division of level 1.

Figure 6—figure supplement 5. The population-adjusted estimated prevalence (median ± 95% BCI) in 1998 in four countries at administrative division of level 1.

Figure 6—figure supplement 5.

(A) Cambodia, (B) Laos, (C) Thailand, and (D) Vietnam.
Figure 6—figure supplement 5—source data 1. The results of the population-adjusted estimated prevalence in 1998 in four countries at administrative division of level 1.

Figure 6—figure supplement 6. The population-adjusted estimated prevalence (median ± 95% BCI) in 1993 in four countries at administrative division of level 1.

Figure 6—figure supplement 6.

(A) Cambodia, (B) Laos, (C) Thailand, and (D) Vietnam.
Figure 6—figure supplement 6—source data 1. The results of the population-adjusted estimated prevalence in 1993 in four countries at administrative division of level 1.

Figure 6—figure supplement 7. The population-adjusted estimated prevalence (median ± 95% BCI) in 1988 in four countries at administrative division of level 1.

Figure 6—figure supplement 7.

(A) Cambodia, (B) Laos, (C) Thailand, and (D) Vietnam.
Figure 6—figure supplement 7—source data 1. The results of the population-adjusted estimated prevalence in 1988 in four countries at administrative division of level 1.

Figure 6—figure supplement 8. The population-adjusted estimated prevalence (median ± 95% BCI) in 1983 in four countries at administrative division of level 1.

Figure 6—figure supplement 8.

(A) Cambodia, (B) Laos, (C) Thailand, and (D) Vietnam.
Figure 6—figure supplement 8—source data 1. The results of the population-adjusted estimated prevalence in 1983 in four countries at administrative division of level 1.

Figure 6—figure supplement 9. The population-adjusted estimated prevalence (median ± 95% BCI) in 1978 in four countries at administrative division of level 1.

Figure 6—figure supplement 9.

(A) Cambodia, (B) Laos, (C) Thailand, and (D) Vietnam.
Figure 6—figure supplement 9—source data 1. The results of the population-adjusted estimated prevalence in 1978 in four countries at administrative division of level 1.